iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
29 Fevereiro 2024 - 6:30PM
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital
healthcare company focused on creating trusted solutions that
detect, predict, and prevent disease, today announced it will use
Epic’s Aura platform to streamline access to iRhythm’s Zio
long-term continuous monitoring and ambulatory mobile cardiac
telemetry services ("Zio services”) through improved operational
efficiency for clinicians.
“Our work with Epic aligns with our goal to optimize clinician
workflow efficiencies and provide seamless access to our Zio
services. By integrating Zio services into healthcare providers'
EHR platforms, we are not just simplifying operations but
empowering our health system customers to devote more time to
patient care,” said Quentin Blackford, president and chief
executive officer of iRhythm. “We believe this integration
facilitates improved patient care, ensuring that our customers and
their staff can focus on what truly matters—patient health. We are
committed to continuous investment in our systems and services to
make healthcare more efficient, secure, and patient-focused.”
Through this collaboration, iRhythm and Epic will give
healthcare organizations the ability to more efficiently implement
Zio services. Through Aura, Epic’s specialty diagnostics and
devices suite, we estimate that organizations can save up to 75% of
the time it typically takes to integrate Zio services into their
local instance of Epic software. iRhythm has already surpassed 1.5
million all-time registrations for Zio services received through
EHR-integrated customers. The company estimates this has translated
to hundreds of thousands of hours and millions of dollars in staff
time costs saved by health systems.
“iRhythm is the first medical device manufacturer to join the
Epic community—an addition that reflects the continued growth of
the health grid and a more collaborative healthcare ecosystem,”
said Alan Hutchison, vice president at Epic. “With longitudinal
cardiac data at their fingertips, providers across care settings
can more effectively identify and treat the arrhythmias that
one-off tests sometimes miss. This kind of technology sets the
stage for the eventual proactive monitoring of patients who are at
risk for arrhythmias before their symptoms become severe.”
Through this collaboration, iRhythm’s Zio service will be more
readily available to healthcare providers using Epic—and the more
than 250 million patients in the U.S. who have a record in
Epic.
iRhythm is partnering with early adopter customers to integrate
Zio services into the Aura network across their health systems in
Q4 2024, and the company expects to begin offering this solution to
existing and new Zio customers starting in early 2025.
To learn more about how Zio can integrate with your Epic system,
please visit Epic’s online showroom. To learn more about iRhythm,
please visit https://www.irhythmtech.com/.
- Zio monitor, XT, and AT are contraindicated for critical care
patients
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates
trusted solutions that detect, predict, and prevent disease.
Combining wearable biosensors and cloud-based data analytics with
powerful proprietary algorithms, iRhythm distills data from
millions of heartbeats into clinically actionable information.
Through a relentless focus on patient care, iRhythm’s vision is to
deliver better data, better insights, and better health for
all.
Investor ContactStephanie Zhadkevich(919)
452-5430investors@irhythmtech.com
Media ContactSaige Smith(262)
289-7065irhythm@highwirepr.com
iRhythm Technologies (NASDAQ:IRTC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
iRhythm Technologies (NASDAQ:IRTC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024